Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program

By afschroeder • May 6, 2026

Zhang Y, Nguyen NQH, Hanson PA, Sevilla-Gonzalez M, Haessler J, Sarnowski C, Yao J, Yu B, Jamshidi A, Boerwinkle E, Brown MR, Chen ZZ, Ida Chen YD, Clish C, DiCorpo D, Durda P, Gerszten R, Goodarzi MO, Guo X, Heard-Costa NL, Johnson WC, Kooperberg C, Pankow JS, Post WS, Reiner AP, Rich SS, Rotter JI, de Vries PS, Wood AC, Taylor KD, Manning AK, Dupuis J, Meigs JB, Liu CT. Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program. Atherosclerosis. 2026 Apr 26;417:120758. doi: 10.1016/j.atherosclerosis.2026.120758. Epub ahead of print. PMID: 42085744.

Tags: Biomarker identification, cardiovascular disease, Cedars Sinai DoM, Endocrinology, Plasma metabolomics, Publications, Type 2 diabetes

Related Posts

A Single-Cell Atlas of Diabetes-Associated Remodeling in the Human Corneal Limbus

Zha D, Wang Y, Shah R, Ebrahimi SM, Poe AJ, Amador C, Inzalaco J, Fealy A, Sawant OB, Kramerov AA, Wang ZP, Ljubimov AV, Saghizadeh[...]

Use of Myocardial Perfusion Imaging to Guide Prognosis and Management in Older Adults: Is There an Age Limit?

Patel KK, Miller RJH, Lemley M, Shanbhag A, Ramirez G, Liang JX, Acampa W, Bateman TM, Dorbala S, Einstein AJ, Hauser MT, Kaufmann PA, Feher[...]

Bioactive Lipids of Cardiorespiratory Fitness Insights From Exercise Models in Humans, Mice, and Burmese Pythons

Guseh JS, Roshandelpoor A, Alotaibi M, Zarbafian S, Lau ES, Kuznetsov A, Rosenzweig A, Saeidi N, Choudhary A, Jain M, Cheng S, Lewis GD, Ho[...]